Your browser doesn't support javascript.
loading
The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.
Lavebratt, C; Olsson, S; Backlund, L; Frisén, L; Sellgren, C; Priebe, L; Nikamo, P; Träskman-Bendz, L; Cichon, S; Vawter, M P; Osby, U; Engberg, G; Landén, M; Erhardt, S; Schalling, M.
Afiliação
  • Lavebratt C; 1] Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden [2] Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Olsson S; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Backlund L; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Frisén L; 1] Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden [2] Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden [3] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Sellgren C; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Priebe L; 1] Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany [2] Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • Nikamo P; 1] Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden [2] Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Träskman-Bendz L; Department of Clinical Sciences, University Hospital, Lund, Sweden.
  • Cichon S; 1] Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany [2] Institute of Human Genetics, University of Bonn, Bonn, Germany [3] Institute of Neuroscience and Medicine (INM-1), Structural and Functional Organization of the Brain, Genomic Imaging, Research Center Juelich, Ju
  • Vawter MP; Functional Genomics Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Osby U; 1] Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden [2] Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden [3] Department of Psychiatry, Tiohundra AB, Norrtälje, Sweden.
  • Engberg G; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Landén M; 1] Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden [2] Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.
  • Erhardt S; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Schalling M; 1] Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden [2] Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Mol Psychiatry ; 19(3): 334-41, 2014 Mar.
Article em En | MEDLINE | ID: mdl-23459468

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Transtorno Bipolar / Quinurenina 3-Mono-Oxigenase / Ácido Cinurênico Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Psychiatry Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Transtorno Bipolar / Quinurenina 3-Mono-Oxigenase / Ácido Cinurênico Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Psychiatry Ano de publicação: 2014 Tipo de documento: Article